148 related articles for article (PubMed ID: 8180103)
1. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity.
McDonnell DP; Shahbaz MM; Vegeto E; Goldman ME
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):425-32. PubMed ID: 8180103
[TBL] [Abstract][Full Text] [Related]
2. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.
Vegeto E; Shahbaz MM; Wen DX; Goldman ME; O'Malley BW; McDonnell DP
Mol Endocrinol; 1993 Oct; 7(10):1244-55. PubMed ID: 8264658
[TBL] [Abstract][Full Text] [Related]
3. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
Tung L; Mohamed MK; Hoeffler JP; Takimoto GS; Horwitz KB
Mol Endocrinol; 1993 Oct; 7(10):1256-65. PubMed ID: 8123133
[TBL] [Abstract][Full Text] [Related]
4. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism.
McDonnell DP; Goldman ME
J Biol Chem; 1994 Apr; 269(16):11945-9. PubMed ID: 8163495
[TBL] [Abstract][Full Text] [Related]
5. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Meyer ME; Pornon A; Ji JW; Bocquel MT; Chambon P; Gronemeyer H
EMBO J; 1990 Dec; 9(12):3923-32. PubMed ID: 2249658
[TBL] [Abstract][Full Text] [Related]
6. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
7. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
Sartorius CA; Tung L; Takimoto GS; Horwitz KB
J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487
[TBL] [Abstract][Full Text] [Related]
8. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
9. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.
Beck CA; Weigel NL; Moyer ML; Nordeen SK; Edwards DP
Proc Natl Acad Sci U S A; 1993 May; 90(10):4441-5. PubMed ID: 8389450
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor and the mechanism of action of progesterone antagonists.
Edwards DP; Altmann M; DeMarzo A; Zhang Y; Weigel NL; Beck CA
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):449-58. PubMed ID: 7626494
[TBL] [Abstract][Full Text] [Related]
11. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene.
Giangrande PH; McDonnell DP
Recent Prog Horm Res; 1999; 54():291-313; discussion 313-4. PubMed ID: 10548881
[TBL] [Abstract][Full Text] [Related]
12. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor.
Giangrande PH; Pollio G; McDonnell DP
J Biol Chem; 1997 Dec; 272(52):32889-900. PubMed ID: 9407067
[TBL] [Abstract][Full Text] [Related]
13. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.
Giangrande PH; Kimbrel EA; Edwards DP; McDonnell DP
Mol Cell Biol; 2000 May; 20(9):3102-15. PubMed ID: 10757795
[TBL] [Abstract][Full Text] [Related]
14. Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isoforms.
Kuil CW; Brouwer A; van der Saag PT; van der Burg B
J Biol Chem; 1998 Apr; 273(15):8829-34. PubMed ID: 9535862
[TBL] [Abstract][Full Text] [Related]
15. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.
Wen DX; Xu YF; Mais DE; Goldman ME; McDonnell DP
Mol Cell Biol; 1994 Dec; 14(12):8356-64. PubMed ID: 7969170
[TBL] [Abstract][Full Text] [Related]
16. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
17. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor.
Xu J; Nawaz Z; Tsai SY; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12195-9. PubMed ID: 8901556
[TBL] [Abstract][Full Text] [Related]
18. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.
Klein-Hitpass L; Cato AC; Henderson D; Ryffel GU
Nucleic Acids Res; 1991 Mar; 19(6):1227-34. PubMed ID: 2030942
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
[TBL] [Abstract][Full Text] [Related]
20. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA; Altmann M; Edwards DP
Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
